Insider transactions at Tarsus Pharmaceuticals over the past...
Insider transactions at Tarsus Pharmaceuticals over the past year are not encouraging. Despite insiders owning shares, the net investment doesn't inspire much confidence.
Tarsus Pharmaceuticals Insiders Benefitted From Selling Stock At US$12.72
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment